TA-p63-γ regulates expression of ΔN-p63 in a manner that is sensitive to p53 (original) (raw)

References

• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF . (2003). Proc Natl Acad Sci USA 100: 3983–3988.
• Brunner HG, Hamel BC, Bokhoven Hv H . (2002). Am J Med Genet 112: 284–290.
• Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP et al. (1999). Cell 99: 143–153.
• Chepko G, Smith GH . (1999). J Mammary Gland Biol Neoplasia 4: 35–52.
• Clarke RB, Anderson E, Howell A, Potten CS . (2003). Cell Prolif 36(Suppl 1): 45–58.
• Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J et al. (2002). Clin Cancer Res 8: 494–501.
• Dick JE . (1996). Semin Immunol 8: 197–206.
• DiRenzo J, Signoretti S, Nakamura N, Rivera-Gonzalez R, Sellers W, Loda M et al. (2002). Cancer Res 62: 89–98.
• Dohn M, Zhang S, Chen X . (2001). Oncogene 20: 3193–3205.
• Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ et al. (2003). Genes Dev 17: 1253–1270.
• Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, Curtin JC et al. (2003). Oncogene 22: 7607–7616.
• Hope KJ, Jin L, Dick JE . (2004). Nat Immunol 5: 738–743.
• Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ et al. (2000). Oncogene 19: 1052–1058.
• Jerry DJ, Pinkas J, Kuperwasser C, Dickinson ES, Naber SP . (1999). J Mammary Gland Biol Neoplasia 4: 177–181.
• Kaelin Jr WG . (1999). Oncogene 18: 7701–7705.
• Koster MI, Huntzinger KA, Roop DR . (2002). J Invest Dermatol Symp Proc 7: 41–45.
• Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR . (2004). Genes Dev 18: 126–131.
• Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ et al. (1996). Science 274: 948–953.
• Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A . (1999). Nature 398: 708–713.
• Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ . (2003). Nature 425: 962–967.
• Nylander K, Coates PJ, Hall PA . (2000). Int J Cancer 87: 368–372.
• Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, Zhanxiang W et al. (2002). J Pathol 198: 417–427.
• Pardal R, Clarke MF, Morrison SJ . (2003). Nat Rev Cancer 3: 895–902.
• Parsa R, Yang A, McKeon F, Green H . (1999). J Invest Dermatol 113: 1099–1105.
• Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S et al. (2001). Proc Natl Acad Sci USA 98: 3156–3161.
• Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K, Sidransky D . (2001). Proc Natl Acad Sci USA 98: 1817–1822.
• Rosner B, Colditz GA, Willett WC . (1994). Am J Epidemiol 139: 819–835.
• Smalley M, Ashworth A . (2003). Nat Rev Cancer 3: 832–844.
• Smith GH, Chepko G . (2001). Microsc Res Tech 52: 190–203.
• Suliman Y, Opitz OG, Avadhani A, Burns TC, El-Deiry W, Wong DT et al. (2001). Cancer Res 61: 6467–6473.
• Trosko JE, Chang CC . (2003). Oncol Res 13: 353–357.
• van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH et al. (2001). Am J Hum Genet 69: 481–492.
• van Bokhoven H, McKeon F . (2002). Trends Mol Med 8: 133–139.
• Waltermann A, Kartasheva NN, Dobbelstein M . (2003). Oncogene 22: 5686–5693.
• Welm AL, Kim S, Welm BE, Bishop JM . (2005). Proc Natl Acad Sci USA 102: 4324–4329.
• Welm B, Behbod F, Goodell MA, Rosen JM . (2003). Cell Prolif 36(Suppl 1): 17–32.
• Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC et al. (2003). Cancer Res 63: 2351–2357.
• Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. (1998). Mol Cell 2: 305–316.
• Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. (1999). Nature 398: 714–718.
• Ying H, Chang DL, Zheng H, McKeon F, Xiao ZX . (2005). Mol Cell Biol 25: 6154–6164.

Download references